TOP 100 COSMETIC SITES
| |||
|
| |||
| |||
|
| |||
| ASPS Urges Team Approach To Breast Reconstruction Actress Christina Applegate's public disclosure of her breast cancer, her decision to have a double mastectomy, and plans to go forth with breast reconstruction, calls attention to the need for a medical "team" approach in the treatment and recovery from breast cancer. medicalnewstoday.com |
L.W. Gatz Announces A New Breast Sizing System For Women Considering Breast Augmentation Surgery Deciding on a breast implant size can be a challenging and emotional decision for many women considering breast augmentation. Selecting the incorrect implant size is one of the most common reasons women undergo subsequent surgeries. L.W. Gatz has created the Purlz™ Breast Sizing System to help patients choose right the first time. Breast Sizing Purlz™ are tester implants designed to simulate the effect of various implant sizes on a woman's body. medicalnewstoday.com |
In Cosmetic Surgery Less Common Procedures Less Common Than Thought The American Academy of Cosmetic Surgery announces the results of its 2009 Less Common Cosmetic Procedures consumer survey. While the media has coined these cosmetic procedures as 'fringe' and made it seem that they are in high demand, it is important to clarify the facts. The results reveal that less common cosmetic procedures are generally over-hyped and over-analyzed. medicalnewstoday.com |
Course Set For Innovations In Breast Cancer Surgery The American Society of Breast Disease will convene its third annual School of Oncoplastic Surgery, December 4-6, 2008, at the Embassy Suites Hotel, Dallas-Frisco, Texas. medicalnewstoday.com |
Albany Plastic Surgery Group Pleads Guilty In Connection With Use Of Unlicensed "Botox" Substitute On Unsuspecting Patients The Plastic Surgery Group, LLP ("TPSG"), of Albany, New York, pled guilty to one felony count of misbranding drugs in connection with the use, on unsuspecting patients, of a cheaper "BOTOX" substitute that was not approved by the Food and Drug Administration. TPSG admitted that, with intent to mislead, it injected patients with Botulinum Toxin Type A manufactured by Toxin Research International, Inc. medicalnewstoday.com |